Introducing the Pathway Drug Reference 💊

In clinical practice, quick access to reliable drug information is not just a necessity—it's a lifeline. With up to a third of point-of-care searches revolving around drug-related queries, the importance of swift, accurate drug data cannot be overstated.

That's precisely why we're thrilled to announce a major leap forward in Pathway's clinical decision support platform: the launch of the Pathway Drug Reference in a public preview last week.

This latest feature is a direct response to the invaluable feedback we've received from our users, and it signifies a significant enhancement to the Pathway ecosystem.

What sets the Pathway Drug Reference apart?

• Evidence-Based: All drug information is succinct and backed by official drug labels, current clinical practice guidelines, and the latest studies.
• Physician-Vetted: Our drug information database isn't just comprehensive—it's curated and verified by physicians, offering unparalleled reliability.
• Seamlessly Integrated: The Pathway Drug Reference is not a standalone tool; it's fully integrated with Pathway AI, allowing for a cohesive and intuitive user experience. This integration means you can ask Pathway AI for drug-related information, including indications, dosages, and more.

This feature is available across all Pathway platforms, including our web and mobile apps. We're adding support for new drugs daily.

Here are some examples of drug information questions on Pathway AI:

• buspirone indications and dosage
• semaglutide dosage and indications
• alendronate dose for corticosteroid-induced osteoporosis

But we're not stopping here. The future of clinical decision support is bright, and at Pathway, we're committed to continually advancing and refining our tools to meet the evolving needs of healthcare professionals.

Stay tuned for more updates as we forge ahead to transform clinical decision support.

Thank you for being a part of this journey with us!